SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
NCT07145190
·
clinicaltrials.gov ↗
RECRUITING
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
SL-APO
Sponsor
Bial - Portela C S.A.